Diagnosis and management of acquired coagulation inhibitors: A guideline from UKHCDO

British Journal of Haematology

Volumn 162, Issue 6, 2013, Pages 758-773

  W Collins, Peter ^a   Chalmers, Elizabeth ^b   Hart, Daniel ^c   Jennings, Ian ^d   Liesner, Ri ^e   Rangarajan, Savita ^f   Talks, Kate ^g   Williams, Michael ^h   R M Hay, Charles ⁱ  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UK NEQAS Blood Coagulation   (United Kingdom)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^f BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^g NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^h BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

ⁱ UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Acquired; Autoimmune; Coagulation factor; Factor VIII; Inhibitor

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; DESMOPRESSIN; FIBRIN; FIBRINOGEN INHIBITOR; HEMOSTATIC AGENT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LUPUS ANTICOAGULANT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; PROTEIN INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB; STEROID; TACROLIMUS; TRANEXAMIC ACID; UNCLASSIFIED DRUG; VINCRISTINE;

ANTIBODY TITER; ARTICLE; BLEEDING; BLOOD CLOTTING TEST; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMORBIDITY; COMPARATIVE EFFECTIVENESS; CRYOPRECIPITATION; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG MONITORING; DRUG SAFETY; EDUCATION; ERADICATION THERAPY; HEALTH CARE ORGANIZATION; HEMOPHILIA; HEMOPHILIA A; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; IATROGENIC BLEEDING; IMMUNOADSORPTION; IMMUNOLOGICAL TOLERANCE; INFECTION; INVASIVE PROCEDURE; KIDNEY DISEASE; LABORATORY DIAGNOSIS; MAINTENANCE THERAPY; MENTAL DISEASE; MONOTHERAPY; MORTALITY; MUCOSAL BLEEDING; NEUTROPENIA; ORAL BLEEDING; PARTIAL THROMBOPLASTIN TIME; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PROTEIN POLYMERIZATION; PROTHROMBIN TIME; RELAPSE; REMISSION; RENAL TRACT BLEEDING; SKIN BLEEDING; THERAPY DELAY; THROMBOELASTOGRAPHY; THROMBOSIS; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT RESPONSE; UNITED KINGDOM;

ACQUIRED; AUTOIMMUNE; COAGULATION FACTOR; FACTOR VIII; INHIBITOR;

AGED; AGED, 80 AND OVER; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTOR INHIBITORS; FACTOR VIII; HUMANS; VON WILLEBRAND FACTOR;

EID: 84883293540     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12463     Document Type: Article

References (120)

1. Aggarwal, A., Grewal, R., Green, R.J., Boggio, L., Green, D., Weksler, B.B., Wiestner, A. & Schechter, G.P. (2006) Rituximab for autoimmune haemophilia: a proposed treatment algorithm. Haemophilia, 11, 13-19.
2. Ajzner, E., Balogh, I., Haramura, G., Boda, Z., Kalmar, K., Pfliegler, G., Dahlback, B. & Muszbek, L. (2003) Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding. Journal of Thrombosis and Haemostasis, 1, 943-949.
3. Astermark, J., Donfield, S.M., DiMichele, D.M., Gringeri, A., Gilbert, S.A., Waters, J. & Berntorp, E. (2007) A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) study. Blood, 109, 546-551.
4. Au, W.Y., Lam, C.C. & Kwong, Y.L. (2004) Successful treatment of acquired factor VIII inhibitor with cyclosporin. Haemophilia, 10, 98-100.
5. Banninger, H., Hardegger, T., Tobler, A., Barth, A., Schupbach, P., Reinhart, W., Lammle, B. & Furlan, M. (1993) Fibrin glue in surgery - frequent development of inhibitors of bovine thrombin and human Factor-V. British Journal of Haematology, 85, 528-532.
6. Baudo, F., Collins, P.W., Huth-Kuhne, A., Levesque, H., Marco, P., Nemes, L., Pelligrini, F., Tengborg, L. & Knoebl, P. (2012) Management of bleeding in acquired hemophilia A: results of the European Acquired Haemophilia (EACH2) registry. Blood, 120, 39-46.
7. Billon, S., Le Niger, C., Escoffre-Barbe, M., Vicariot, M. & Abgrall, J.F. (2001) The use of recombinant factor VIIa (NovoSeven (R)) in a patient with a factor XI deficiency and a circulating anticoagulant. Blood Coagulation & Fibrinolysis, 12, 551-553.
8. Bitting, R.L., Bent, S., Li, Y. & Kohlwes, J. (2009) The prognosis and treatment of acquired hemophilia: a systematic review and meta-analysis. Blood Coagulation & Fibrinolysis, 20, 517-523.
9. Boehlen, F., Casini, A., Chizzolini, C., Mansouri, B., Kohler, H.P. & Schroeder, V. (2013) Acquired factor XIII deficiency: a therapeutic challenge. Thrombosis and Haemostasis, 109, 479-487.
10. Boggio, L. & Green, D. (2001) Recombinant human factor VIIa in the management of amyloid-associated factor X deficiency. British Journal of Haematology, 112, 1074-1075.
11. Boles, J.C., Key, N.S., Kasthuri, R. & Ma, A.D. (2011) Single centre experience of rituximab as first-line immunosuppression for acquired haemophilia. Journal of Thrombosis and Haemostasis, 9, 1429-1431.
12. Canoso, R.T., Hutton, R.A. & Deykin, D. (1977) Chlorpromazine-induced inhibitor of blood-coagulation. American Journal of Hematology, 2, 183-191.
13. Castro, O., Farber, L.R. & Clyne, L.P. (1972) Circulating anticoagulants against factor-IX and factor-XI in systemic lupus-erythematosus. Annals of Internal Medicine, 77, 543-548.
14. Chediak, J., Ashenhurst, J.B., Garlick, I. & Desser, R.K. (1980) Successful Management of Bleeding in A Patient with Factor-V Inhibitor by Platelet Transfusions. Blood, 56, 835-841.
15. Coller, B.S., Hultin, M.B., Hoyer, L.W., Miller, F., Dobbs, J.V., Dosik, M.H. & Berger, E.R. (1981) Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosis. Blood, 58, 619-624.
16. Collins, P.W. (2011) Mangement of acquired haemophilia A. Journal of Thrombosis and Haemostasis, 9, 226-235.
17. Collins, H.W. & Gonzalez, M.F. (1984) Acquired factor-IX inhibitor in a patient with adenocarcinoma of the colon. Acta Haematologica, 71, 49-52.
18. Collins, P.W. & Percy, C.L. (2010) Advances in the understanding of acquired haemophilia A: implications for clinical practice. British Journal of Haematology, 148, 183-194.
19. Collins, P., Macartney, N., Davies, R., Lees, S., Giddings, J. & Majer, R. (2004) A population based, unselected, consecutive cohort of patients with acquired haemophilia A. British Journal of Haematology, 124, 86-90.
20. Collins, P.W., Hirsch, S., Baglin, T.P., Dolan, G., Hanley, J., Makris, M., Keeling, D.M., Liesner, R., Brown, S.A. & Hay, C.R.M. (2007) Acquired haemophilia A in the UK: a two year national surveillance study by UK Haemophilia Centre Doctors' Organisation. Blood, 109, 1870-1877.
21. Collins, P.W., Baudo, F., Knoebl, P., Levesque, H., Nemes, L., Pelligrini, F., Marco, P., Tengborg, L. & Huth-Kuhne, A. (2012) Immunosuppression for acquired hemophilia A: results of the European Acquired Haemophilia (EACH) registry. Blood, 120, 47-55.
22. Collins, P.W., Chalmers, E., Hart, D.P., Liesner, R., Rangarajan, S., Talks, K., Williams, M., Hay, C.R., UK Haemophilia Centre Doctors (2013) Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization. British Journal of Haematology, 160, 153-70.
23. Craddock, C.G., Adams, W.S. & Figueroa, W.G. (1953) Interference with fibrin formation in multiple myeloma by an unusual protein found in blood and urine. Journal of Laboratory and Clinical Medicine, 42, 847-859.
24. Currie, M.S., Stein, A.M., Rustagi, P.K., Behrens, A.N. & Logue, G.L. (1984) Transient acquired factor-x deficiency associated with pneumonia. New York State Journal of Medicine, 84, 572-573.
25. Dedeken, L., St Louis, J., Demers, C., Meilleur, C. & Rivard, G.E. (2009) Postpartum acquired haemophilia: a single centre experience with rituximab. Haemophilia, 15, 1166-1168.
26. Dehmel, H., Werwitzke, S., Trummer, A., Ganser, A. & Tiede, A. (2008) Thrombelastographic monitoring of recombinant factor VIIa in acquired haemophilia. Haemophilia, 14, 736-742.
27. Delgado, J., Jimenez-Yuste, V., Hernandez-Navarro, F. & Villar, A. (2003) Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. British Journal of Haematology, 121, 21-35.
28. Dragani, A., Febo, F., Pennese, E., Rolandi, G., Spadano, A. & Davi, G. (2004) Acquired haemophilia masked by heparin therapy. International Journal of Immunopathology & Pharmacology, 17, 227-228.
29. Emori, Y., Sakugawa, M., Niiya, K., Kiguchi, T., Kojima, K., Takenaka, K., Shinagawa, K., Ishimaru, F., Ikeda, K., Tanimoto, M., Yamasaki, R., Ohara, N. & Harada, M. (2002) Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis. Blood Coagulation & Fibrinolysis, 13, 555-559.
30. Favaloro, E., Bonar, R., Duncan, E., Earl, G., Low, J., Aboud, M., Just, S., Sioufi, J., Street, A. & Marsden, K. (2006) Idendification of factor inhibitors by diagnostic haemostatic laboratories: a large multicentre evaluation. Thrombos and Haemostas, 96, 73-78.
31. Feinstein, D.I. (1978) Acquired inhibitors of factor-V. Thrombosis and Haemostasis, 39, 663-674.
32. Flaherty, M.J., Henderson, R. & Wener, M.H. (1989) Iatrogenic immunization with bovine thrombin - a mechanism for prolonged thrombin times after surgery. Annals of Internal Medicine, 111, 631-634.
33. Fleck, R.A., Rapaport, S.I. & Rao, L.V.M. (1988) Anti-prothrombin antibodies and the lupus anticoagulant. Blood, 72, 512-519.
34. Franchini, M. & Lippi, G. (2008) Acquired factor VIII inhibitors. Blood, 112, 250-255.
35. Franchini, M. & Lippi, G. (2011) The use of desmopressin in acquired haemophilia A: a systematic review. Blood Transfusion, 9, 377-382.
36. Freedman, J., Rand, M.L., Russell, O., Davis, C., Cheatley, P.L., Blanchette, V. & Garvey, M.B. (2003) Immunoadsorption may provide a cost-effective approach to management of patients with inhibitors to FVIII. Transfusion, 43, 1508-1513.
37. Frick, P.G. (1955) Inhibition of conversion of fibrinogen to fibrin by abnormal proteins in multiple myeloma. American Journal of Clinical Pathology, 25, 1263-1273.
38. Gabriel, D.A., Carr, M.E., Cook, L. & Roberts, H.R. (1987) Spontaneous antithrombin in a patient with benign paraprotein. American Journal of Hematology, 25, 85-93.
39. Gawryl, M.S. & Hoyer, L.W. (1982) Inactivation of factor VIII coagulant activity by two different types of human antibodies. Blood, 60, 1103-1109.
40. Goldsmith, G.H. & Silverman, P. (1985) Inhibitors of plasma thromboplastin antecedent (factor-XI) - studies on mechanism of inhibition. Journal of Laboratory and Clinical Medicine, 106, 279-285.
41. Goodrick, M.J., Prentice, A.G., Copplestone, J.A., Pamphilon, D.H. & Boon, R.J. (1992) Acquired factor-XI inhibitor in chronic lymphocytic-leukemia. Journal of Clinical Pathology, 45, 352-353.
42. Gootenberg, J.E. (1998) Factor concentrates for the treatment of factor XIII deficiency. Current opinion in hematology, 5, 372-375.
43. Green, D. & Lechner, K. (1981) A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thrombosis & Haemostasis, 45, 200-203.
44. Green, D., Rademaker, A.W. & Briet, E. (1993) A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thrombosis & Haemostasis, 70, 753-757.
45. Gregory, T.F. & Cooper, B. (2006) Case report of an acquired FXIII inhibitor: diagnosis and management. Proceedings (Baylor University Medical Center), 19, 221-223.
46. Gris, J.C., Schved, J.F., Branger, B., Aguilarmartinez, P., Vecina, F., Oules, R., Sarlat, C. & Fourcade, J. (1992) Autoantibody to plasma fibrinopeptide-A in a patient with a severe acquired hemorrhagic syndrome. Blood Coagulation & Fibrinolysis, 3, 519-529.
47. Guillet, B., Kriaa, F., Huysse, M.G., Proulle, V., George, C., Tchernia, G., D'Oiron, R., Laurian, Y., Charpentier, B., Lambert, T. & Dreyfus, M. (2001) Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophilia. British Journal of Haematology, 114, 837-844.
48. Haj, M., Dasani, H., Kundu, S., Mohite, U. & Collins, P.W. (2004) Acquired haemophilia A may be associated with clopidogrel. BMJ, 329, 323.
49. Hauser, I., Schneider, B. & Lechner, K. (1995) Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment. Thrombosis & Haemostasis, 73, 1-5.
50. Hay, C.R.M. (2012) Acquired disorders of coagulation: the immune coagulopathies. In: Hemostasis and Thrombosis (eds. V.J. Marder, W.C. Aird, J.S. Bennett, S. Schulman & G.C. White ), edn 6, pp. 723-737. Lippincott, Williassms and Wilkins, Philadelphia, PA.
51. Hay, C.R., Negrier, C. & Ludlam, C.A. (1997) The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thrombosis & Haemostasis, 78, 1463-1467.
52. Hay, C.R.M., Brown, S.A., Collins, P.W., Keeling, D.M. & Liesner, R. (2006) The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. British Journal of Haematology, 133, 591-605.
53. Henson, K., Files, J.C. & Morrison, F.S. (1989) Transient acquired factor-X deficiency - report of the use of activated clotting concentrate to control a life-threatening hemorrhage. American Journal of Medicine, 87, 583-585.
54. ®)) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A - a two-centre experience. Haemophilia, 18, 544-549.
55. Hsieh, L. & Nugent, D. (2008) Factor XIII deficiency. Haemophilia, 14, E69-E73.
56. Huth-Kuhne, A., Baudo, F., Collins, P., Ingerslev, J., Kessler, C., Levesque, H., Castellano, M., Shima, M. & St Louis, J. (2009) International recommendations on the diagnosis and treatment of patients with acquired haemophilia A. Haematologica, 94, 566-575.
57. Ingerslev, J. & Sorensen, B. (2011) Parallel use of by-passing agents in haemophilia with inhibitors: a critical review. British Journal of Haematology, 155, 256-262.
58. Italian Association of Haemophilia Centres (AICE) (2006) Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Registry relevant to clinical practice. International Journal of Obstetrics and Gynaecology, 110, 311-314.
59. Kalafatis, M., Simioni, P., Tormene, D., Beck, D.O., Luni, S. & Girolami, A. (2002) Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations. Blood, 99, 3985-3992.
60. Keeling, D., Mackie, I., Moore, G.W., Greer, I.A. & Greaves, M. (2012) Guidelines on the investigation and management of antiphospholipid syndrome. British Journal of Haematology, 157, 47-58.
61. Knobl, P., Tribl, B. & Lechner, K. (1997) Acquired factor V inhibitors: a review of the literature. Thrombosis and Haemostasis, O2423.
62. Knobl, P., Marco, P., Baudo, F., Collins, P., Huth-Kuhne, A., Nemes, L., Pelligrini, F., Tengborg, L. & Levesque, H. (2012) Demographics and clinical data in acquired hemophilia A:results of the European Acquired Heamophilia (EACH2) registry. Journal of Thrombosis and Haemostasis, 10, 622-631.
63. Krieger, H., Leddy, J.P. & Breckenridge, R.T. (1975) Studies on a circulating anticoagulant in systemic lupus-erythematosus - evidence for inhibition of function of activated plasma thromboplastin antecedent (factor-11A). Blood, 46, 189-197.
64. Kyriakou, D.S., Alexandrakis, M.G., Passam, F.H., Foundouli, K., Matalliotakis, E., Koutroubakis, I.E., Kourelis, T.V., Chalkiadakis, G. & Manoussos, O.N. (2002) Acquired inhibitors to coagulation factors in patients with gastrointestinal diseases. European Journal of Gastroenterology & Hepatology, 14, 1383-1387.
65. Lackner, H. (1973) Hemostatic abnormalities associated with dysproteinemias. Seminars in Hematology, 10, 125-133.
66. Laffan, M., Brown, S.A., Collins, P.W., Cumming, A.M., Hill, F.G.H., Keeling, D., Peake, I.R. & Pasi, K.J. (2004) The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization. Haemophilia, 10, 199-217.
67. Lankiewicz, M.W. & Bell, W.R. (1992) A Unique Circulating inhibitor with specificity for coagulation factor-X. American Journal of Medicine, 93, 343-346.
68. Largo, R., Sigg, P., Felten, A.V. & Straub, P.W. (1974) Acquired factor-IX inhibitor in A nonhemophilic patient with autoimmune-disease. British Journal of Haematology, 26, 129-140.
69. Lawson, J.H., Pennell, B.J., Olson, J.D. & Mann, K.G. (1990) Isolation and characterization of an acquired antithrombin antibody. Blood, 76, 2249-2257.
70. Lechner, K. (1971) Factor-Ix-Inhibitors - Report of 2 Cases and A Study of Biological, Chemical and Immunological Properties of Inhibitors. Thrombosis et Diathesis Haemorrhagica, 25, 447-448.
71. Lee, G., Duan-Porter, W. & Metjian, A. (2012) Acquired, non-amyloid related factor X deficiency: review of the literature. Haemophilia, 18, 655-663.
72. Lian, E.C., Larcada, A.F. & Chiu, A.Y. (1989) Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Annals of Internal Medicine, 110, 774-778.
73. Lian, E.C., Villar, M.J., Noy, L.I. & Ruiz-Dayao, Z. (2002) Acquired factor VIII inhibitor treated with cyclophosphamide, vincristine, and prednisone. American Journal of Hematology, 69, 294-295.
74. Lorand, L., Velasco, P.T., Hill, J.M., Hoffmeister, K.J. & Kaye, F.J. (2002) Intracranial hemorrhage in systemic lupus erythematosus associated with an autoantibody against factor XIII. Thrombosis and Haemostasis, 88, 919-923.
75. Lottenberg, R., Kentro, T.B. & Kitchens, C.S. (1987) Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy. Archives of Internal Medicine, 147, 1077-1081.
76. Lulla, R.R., Allen, G.A., Zakarija, A. & Green, D. (2009) Transplacental transfer of postpartum inhibitors to factor VIII. Haemophilia, 4, 592-598.
77. Matsunaga, A.T. & Shafer, F.E. (1996) An acquired inhibitor to factor X in a pediatric patient with extensive burns. Journal of Pediatric Hematology Oncology, 18, 223-226.
78. Mazzucconi, M.G., Peraino, M., Bizzoni, L., Bernasconi, S., Luciani, M. & de Rossi, G. (1999) Acquired inhibitor against factor IX in a child: successful treatment with high-dose immunoglobulin and dexamethasone. Haemophilia, 5, 132-134.
79. Michiels, J.J., Hamulyak, K., Nieuwenhuis, H.K., Novakova, I. & van Vliet, H.H. (1997) Acquired haemophilia A in women postpartum: management of bleeding episodes and natural history of the factor VIII inhibitor. European Journal of Haematology, 59, 105-109.
80. Milde, L.N. (1989) An anaphylactic reaction to fibrin glue. Anesthesia and Analgesia, 69, 684-686.
81. Miller, K., Neely, J.E., Krivit, W. & Edson, J.R. (1978) Spontaneously acquired factor-IX inhibitor in a non-hemophiliac child. Journal of Pediatrics, 93, 232-234.
82. Mollica, L., Preston, R.J.S., Chion, A.C.K., Lees, S.J., Collins, P., Lewis, S. & Lane, D.A. (2006) Autoantibodies to thrombin directed against both of its cryptic exosites. British Journal of Haematology, 132, 487-493.
83. Morrison, A.E. & Ludlam, C.A. (1995) Acquired haemophilia and its management. British Journal of Haematology, 89, 231-236.
84. Morrison, A.E., Ludlam, C.A. & Kessler, C. (1993) Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood, 81, 1513-1520.
85. Mudad, R. & Kane, W.H. (1993) DDAVP in acquired hemophilia A: case report and review of the literature. American Journal of Hematology, 43, 295-299.
86. Mulhare, P.E., Tracy, P.B., Golden, E.A., Branda, R.F. & Bovill, E.G. (1991) a case of acquired factor-X deficiency with invivo and invitro evidence of inhibitor activity directed against factor-X. American Journal of Clinical Pathology, 96, 196-200.
87. Mumford, A.D., O'Donnell, J., Gillmore, J.D., Manning, R.A., Hawkins, P.N. & Laffan, M. (2000) Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis. British Journal of Haematology, 110, 454-460.
88. Nakamura, S., Kato, A., Sakata, Y. & Aoki, N. (1988) Bleeding tendency caused by igg inhibitor to factor-XIII, treated successfully by cyclophosphamide. British Journal of Haematology, 68, 313-319.
89. Nemes, L. & Pitlik, E. (2003) Ten years experience with immune tolerance therapy in acquired hemophilia. Haematologica, 88, 106-110.
90. Nemes, L., Tengborg, L., Collins, P., Baudo, F., Huth-Kuhne, A., Knoebl, P., Marco, P. & Levesque, H. (2010) Acquired haemophilia a and pregnancy/postpartum - a report from a european registry. Blood, 116, 717.
91. Nesheim, M.E., Nichols, W.L., Cole, T.L., Houston, J.G., Schenk, R.B., Mann, K.G. & Bowie, E.J.W. (1986) Isolation and study of an acquired inhibitor of human coagulation factor-V. Journal of Clinical Investigation, 77, 405-415.
92. Pardos-Gea, J., Altisent, C., Parra, R., Vilardell-Tarres, M. & Ordi-Ros, J. (2012) Acquired haemophilia A. First line treatment with calcineurin inhibitors and steroid pulses: a 10-year follow-up study. Haemophilia, 18, 789-793.
93. Pasi, K.J., Collins, P.W., Keeling, D.M., Brown, S.A., Cumming, A.M., Dolan, G.C., Hay, C.R., Hill, F.G., Laffan, M. & Peake, I.R. (2004) Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization. Haemophilia, 10, 218-231.
94. Perkins, H.A., Mackenzi, M.R. & Fudenber, H.H. (1970) Hemostatic defects in dysproteinemias. Blood-the Journal of Hematology, 35, 695-707.
95. Peuscher, F.W., Vanaken, W.G., Vanmourik, J.A., Swaak, A.J.G., Sie, L.H. & Statiusvaneps, L.W. (1979) Acquired, transient factor-X (stuart factor) deficiency in a patient with mycoplasma pneumonial infection. Scandinavian Journal of Haematology, 23, 257-264.
96. Pfliegler, G., Boda, Z., Harsfalvi, J., Flora-Nagy, M., Sari, B., Pecze, K. & Rak, K. (1989) Cyclosporin treatment of a woman with acquired haemophilia due to factor VIII:C inhibitor. Postgraduate Medical Journal, 65, 400-402.
97. Rao, L.V.M., Zivelin, A., Iturbe, I. & Rapaport, S.I. (1994) Antibody-induced acute factor-X deficiency - clinical manifestations and properties of the antibody. Thrombosis and Haemostasis, 72, 363-371.
98. de Raucourt, E., Barbier, C., Sinda, P., Dib, M., Peltier, J.Y. & Ternisien, C. (2003) High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors. American Journal of Hematology, 74, 187-190.
99. Reece, E.A., Clyne, L.P., Romero, R. & Hobbins, J.C. (1984) Spontaneous factor-XI Inhibitors - 7 additional cases and a review of the literature. Archives of Internal Medicine, 144, 525-529.
100. Ries, M., Wolfel, D. & Maier-Brandt, B. (1995) Severe intracranial hemorrhage in a newborn infant with transplacental transfer of an acquired factor VIII inhibitor. The Journal of Pediatrics, 127, 649-650.
101. Sallah, S. (2004) Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. Haemophilia, 10, 169-173.
102. Santagostino, E., Mancuso, M.E., Rocino, A., Mancuso, G., Scaraggi, F. & Mannucci, P.M. (2006) A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors. Journal of Thrombosis & Haemostasis, 4, 367-371.
103. Schulman, S., Langevitz, P., Livneh, A., Mortinowitz, U., Seligsohn, U. & Varon, D. (1996) Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus. Thrombosis & Haemostasis, 76, 344-346.
104. Solymoss, S. (1998) Postpartum acquired factor VIII inhibitors: results of a survey. American Journal of Hematology, 59, 1-4.
105. Sperr, W.R., Lechner, K. & Pabinger, I. (2007) Rituximab for the treatment of acquired antibodies to factor VIII. Haematologica, 92, 66-72.
106. Stricker, R.B., Lane, P.K., Leffert, J.D., Rodgers, G.M., Shuman, M.A. & Corash, L. (1988) Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves. Blood, 72, 1375-1380.
107. Sumner, M.J., Geldziler, B.D., Pedersen, M. & Seremetis, S. (2007) Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal. Haemophilia, 13, 451-461.
108. Teitel, J., Berntorp, E., Collins, P., D'Oiron, R., Ewenstein, B., Gomperts, E., Goudemand, J., Gringeri, A., Key, N., Leissinger, C., Monahan, P. & Young, G. (2007) A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitors. Haemophilia, 13, 256-263.
109. Thompson, C.A., Kyle, R., Gertz, M., Heit, J., Pruthi, R. & Pardanani, A. (2010) Systemic AL amyloidosis with acquired factor X deficiency: a study of perioperative bleeding risk and treatment outcomes in 60 patients. American Journal of Hematology, 85, 171-173.
110. Tosetto, A., Rodeghiero, F., Gatto, E., Manotti, C. & Poli, T. (1995) An acquired hemorrhagic disorder of fibrin cross-linking due to igg antibodies to FXIII, successfully treated with FXIII replacement and cyclophosphamide. American Journal of Hematology, 48, 34-39.
111. Tribl, B., Knobl, P., Derfler, K., Kapiotis, S., Aspock, G., Jager, U., Horl, W. & Lechner, K. (1995) Rapid elimination of a high-titer spontaneous factor-v antibody by extracorporeal antibody-based immunoadsorption and immunosuppression. Annals of Hematology, 71, 199-203.
112. Uggla, B., Linder, O. & Schulman, S. (2003) Acquired hemophilia masked by warfarin therapy: report on two cases. Blood Coagulation & Fibrinolysis, 14, 769-772.
113. Vadikolia, C.M., Riddell, A., Brooks, S., Yee, T.T., Brown, S. & Lee, C. (2007) Acquired haemophilia masked by warfarin therapy. International Journal of Laboratory Hematology, 29, 64-68.
114. Vercellotti, G.M. & Mosher, D.F. (1982) Acquired factor-XI deficiency in systemic lupus-erythematosus. Thrombosis and Haemostasis, 48, 250-252.
115. Vivaldi, P., Rossetti, G., Galli, M. & Finazzi, G. (1997) Severe bleeding due to acquired hypoprothrombinemia lupus anticoagulant syndrome. Case report and review of literature. Haematologica, 82, 345-347.
116. Weisdorf, D., Hasegawa, D. & Fair, D.S. (1989) Acquired factor-VII deficiency associated with aplastic-anemia - correction with bone-marrow transplantation. British Journal of Haematology, 71, 409-413.
117. -1 dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison. Haemophilia, 14, 287-294.
118. Zeitler, H., Ulrich-Merzenich, G., Walger, P., Dusing, R., Vetter, H. & Brackmann, H.H. (2006a) The modified Bonn Malmo protocol (MBMP) in the treatment of acquired haemophilia A. Deutsche Medizinische Wochenschrift, 131, 141-147.
119. Zeitler, H., Ulrich-Merzenich, G., Hess, L., Konsek, E., Unkrig, C., Walger, P., Vetter, H. & Brackmann, H.H. (2006b) Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept. Blood, 105, 2287-2293.
120. Zeitler, H., Ulrich-Merzenich, G., Goldmann, G., Vidovic, N., Brackmann, H.H. & Oldenburg, J. (2010) The relevance of the bleeding severity in the treatment of acquired haemophilia - an update of a single-centre experience with 67 patients. Haemophilia, 16, 95-101.